Dr. Rakesh Nagarajan is the Chief Medical Officer at Velsera
The healthcare industry is experiencing a data and technological revolution that is accelerating drug discovery and delivery to patients. Over the past 15 years, we’ve…
Continue Reading
Background: HIV continues to be a public health concern for Mexico and Latin America due to an increase in new cases, instead of a decrease, such as is observed globally. Treatment adherence is a…
Continue Reading
Rare diseases, affecting ~350 million people worldwide, pose significant challenges in clinical diagnosis due to the lack of experienced physicians and the complexity of differentiating between numerous rare diseases. To address these challenges, we…
Continue Reading
Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer’s disease and test that device in clinical trials.The…
Continue Reading
What You Should Know:
– Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities.
– The company’s latest advancement integrates a…
Continue Reading
What You Should Know:
– LunaJoy Health, a women’s mental health company, has launched a series of online educational modules designed to enhance the skills and knowledge of clinical professionals in maternal and women’s mental…
Continue Reading
Simon Rasalingham, chief executive of Behold.ai (Credit: Prix Galien International)
UK-based digital health start-up Behold.ai has entered administration after failing to win any contracts under the government’s AI Diagnostic Fund.
Behold.ai supplies lung cancer AI…
Clinical documentation requirements can be copious and time-consuming. While concurrent documentation is taught and encouraged, it is a skill that takes time to master – and even when done well can cause a clinician…
Continue Reading
What Is Retrieval-Augmented Generation?
With RAG, an LLM is better positioned to optimize its output before generating a response, says Tehsin Syed, Amazon Web Services’ general manager of health AI. This is valuable when a…
Manas AI, an AI-driven drug discovery platform, has launched with $24.6 million in seed round in a round co-led by General Catalyst and LinkedIn cofounder Reid Hoffman. Greylock and other strategic investors participated in the…
Continue Reading
